SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rolf Schoch who wrote ()2/21/1997 11:39:00 AM
From: Jongmans   of 4474
 
Full text Biogen website (Resaerch Pipeline) on Gene Therapy (dated 20 August 1996}

Quote:

"Gene Therapy

Biogen has a major collaborative agreement with a start-up company called GENOVO in the new research area of gene therapy. We believe this is the most important new approach to drug discovery since the earliest days of the biotechnology revolution. The ultimate goal of gene therapy is the replacement of genes, but such direct cures still a long time off.
Immunotherapeutics are much closer at hand.These are protein-based drugs that work like sophisticated vaccines,injecting synthesized DNA directly into affected cells that are part of the diseased organ. Such an approach gives greater specifity in targeting drugs and the ability to treat complex diseases that have a genetic component. Italso provides a drug-delivery system that canhelp turn basic research findings into viable, cost-effective therapies."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News